Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

Cross Asset Strategy

<h2>Review of Top 10 Issues Related to Korean Stock Market, Economy, &amp; Politics in September 2020</h2><ul>
<li><div class="content-highlight">Value &amp; GARP outperforming Growth</div></li>
<li>Big Hit Entertainment IPO </li>
<li>Kakao Games IPO </li>
<li>IPOs of Kakao Pay, Kakao Bank, &amp; Kakao Page in 2021 </li>
<li>A merger of the three Celltrion companies </li>
<li>LG Chem's carve-out of its rechargeable battery business </li>
<li>Big rights offerings by Doosan Heavy Industries &amp; Doosan Fuel Cell </li>
<li>HDC Hyundai Development gives up on Asiana Airlines </li>
<li>Nikola's founder resigns - Impact on Hanwha Solutions</li>
<li>Samsung Electronics (Dividends) </li>
</ul>

Review of Top 10 Issues Related to Korean Stock Market, Economy, &amp; Politics in September 2020
Value &amp; GARP outperforming Growth
Big Hit Entertainment IPO 
Kakao Games IPO 
IPOs of Kakao Pay, Kakao Bank, &amp; Kakao Page in 2021 
A merger of the three Celltrion companies 
LG Chem's carve-out of its rechargeable battery business 
Big rights offerings by Doosan Heavy Industries &amp; Doosan Fuel Cell 
HDC Hyundai Development gives up on Asiana Airlines 
Nikola's founder resigns - Impact on Hanwha Solutions
Samsung Electronics (Dividends) 


Korea Stock Market Monthly Recap #52 (September 2020)

Korea / Special Sits, Pairs, Index Rebalancing, Clepsydra Capital

Sanghyun Park

Korea / Special Sits, Pairs, Index Rebalancing

Event-Driven

Celltrion finally gives us a three-way merger plan in a regulatory filing.Below is the link to the regulatory filing published at DART last Friday after the market closed.<a href="http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20200925800449" target="_blank" rel="noopener">http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20200925800449</a>The filing is brief and straightforward.<ul>
<li>First, there will be a new company named Celltrion Healthcare Holdings. Then, Seo Jung-jin, Founder, will invest his stake of Healthcare into this entity through in-kind investment.</li>
<li>Second, they will merge Celltrion Holdings and Celltrion Healthcare Holdings. The deadline for this merger is December 31, 2021.</li>
<li>Lastly, there will be another merger between Celltrion, Celltrion Healthcare, and Celltrion Pharm. * But the deadline is yet to be announced. Also, the merger mechanism is subject to change depending on the outcome of each company's board and shareholder meeting.
</li>
</ul><figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/161/915/original/1.png?1601171221" class="editor-image img-responsive" data-smartkarma-image-id="161915"></figure><div class="content-caption">(Source: DART)</div>

Celltrion finally gives us a three-way merger plan in a regulatory filing.Below is the link to the regulatory filing published at DART last Friday after the market closed.http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20200925800449The filing is brief and straightforward.
First, there will be a new company named Celltrion Healthcare Holdings. Then, Seo Jung-jin, Founder, will invest his stake of Healthcare into this entity through in-kind investment.
Second, they will merge Celltrion Holdings and Celltrion Healthcare Holdings. The deadline for this merger is December 31, 2021.
Lastly, there will be another merger between Celltrion, Celltrion Healthcare, and Celltrion Pharm. * But the deadline is yet to be announced. Also, the merger mechanism is subject to change depending on the outcome of each company's board and shareholder meeting.

(Source: DART)

Celltrion Merger Announcement: Details, Questionable Aspects, & Trading Dynamics

Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Last Week in Event SPACE: Vedanta, Evergrande Auto, Cocokara, Leyou, Mitsu Lease/Hitachi Cap

<div class="content-highlight">
After the market close today, there was a major announcement in the healthcare sector in Korea. <a href="https://www.smartkarma.com/entities/celltrion-inc" target="_blank" data-smartkarma-citation="entities:991:1" rel="noopener">Celltrion Inc (068270 KS)</a>, <a href="https://www.smartkarma.com/entities/celltrion-healthcare" target="_blank" data-smartkarma-citation="entities:23641:1" rel="noopener">Celltrion Healthcare (091990 KS)</a>, and <a href="https://www.smartkarma.com/entities/celltrion-pharm-inc" target="_blank" data-smartkarma-citation="entities:992:1" rel="noopener">Celltrion Pharm (068760 KS)</a> will be MERGED into one company. Plus, a NEWCO called Celltrion Healthcare Holdings is established.
Overall, we believe that this will be positive for the three Celltrion Group companies over a 6-12 months view. However, the overall impact is not likely to be overly significant since early this year, the Celltrion Group Chairman Seo Jung-Jin already hinted that there could be a merger among these three companies.
One of the main reasons why the Celltrion Group stocks have done well so far this year has been due to the expectation of the formal merger announcement. As a result, there could be some investors that may actually try to sell the three Celltrion Group related stocks on this news in the near-term. 
</div>


After the market close today, there was a major announcement in the healthcare sector in Korea. Celltrion Inc (068270 KS), Celltrion Healthcare (091990 KS), and Celltrion Pharm (068760 KS) will be MERGED into one company. Plus, a NEWCO called Celltrion Healthcare Holdings is established.
Overall, we believe that this will be positive for the three Celltrion Group companies over a 6-12 months view. However, the overall impact is not likely to be overly significant since early this year, the Celltrion Group Chairman Seo Jung-Jin already hinted that there could be a merger among these three companies.
One of the main reasons why the Celltrion Group stocks have done well so far this year has been due to the expectation of the formal merger announcement. As a result, there could be some investors that may actually try to sell the three Celltrion Group related stocks on this news in the near-term. 


A Merger of Three Celltrion Group Companies + Formation of a Celltrion Healthcare Holdings

CEO, A. Stotz Investment Research

Dr. Andrew Stotz, CFA

Quantamental Investing to beat Benchmarks

A. Stotz Investment Research

We pick stocks. We construct portfolios. All our effort is focused on how to better pick stocks and construct portfolios. We serve fund management companies, family offices, and high net worth individuals.

Thematic (Sector/Industry)

We highlight 14 stocks in Asia that look interesting to us based upon our FVMR Methodology. Our research team constantly reviews the Asian markets to try to find interesting ideas based on Fundamentals or Valuation or Momentum or Risk or some combination thereof.

We highlight 14 stocks in Asia that look interesting to us based upon our FVMR Methodology. Our research team constantly reviews the Asian markets to try to find interesting ideas based on Fundamentals or Valuation or Momentum or Risk or some combination thereof.

South Korea

Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Celltrion (068270 KP)

Korea Stock Market Monthly Recap #52 (September 2020)

Review of Top 10 Issues Related to Korean Stock Market, Economy, Politics in September 2020

Douglas Kim

Celltrion Merger Announcement: Details, Questionable Aspects, & Trading Dynamics

Celltrion finally ga

Sanghyun Park

Last Week in Event SPACE: Vedanta, Evergrande Auto, Cocokara, Leyou, Mitsu Lease/Hitachi Cap

Last Week in Event SPACE ... Plus, other events, CCASS movements and Mood Spins. (This insight covers specific insights & comments...

David Blennerhassett

A Merger of Three Celltrion Group Companies + Formation of a Celltrion Healthcare Holdings

Overall, we believe that this will be positive for the three Celltrion Group companies over a 6-12 months view. However, the overall impact is not...

Douglas Kim

The Stocks to Own in Asia – Vol. 30

We highlight 14 stocks in Asia that look interesting to us based upon our FVMR Methodology. Our research team constantly reviews the Asia markets...

A. Stotz Investment Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)